Spanish oncology research outfit Medica Scientia Innovation Research (MEDSIR) is infusing artificial intelligence into its breast cancer trials through a collaboration with Ataraxis AI, with the goal of finding new…
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also…
Worldwide Clinical Trials is looking to grow to global CRO dominance with a new leader at the helm. Longtime president and CEO Peter Benton is retiring, with former Syneos Health…
IQVIA is unveiling a new suite of tools designed to manage all the financial components of clinical trials. The company is using an artificial-intelligence-enabled platform to help remove inefficiencies due…
Clinical software developer PhaseV is teaming up with another global CRO, unveiling a plan to infuse its trial design platform into Bioforum’s services. PhaseV’s Trial Optimizer uses machine learning to…
Global CRO Pi Health has pulled a new partnership out of the oven. Building on a growing presence Down Under, Pi Health will provide CRO services and a clinical trial…
Veeva Systems has unveiled its first big biotech pact since thawing relations with one-time adversary IQVIA, teaming up with Amgen to find ways to improve clinical trial processes. Amgen will…
Chinese contract research and manufacturing outfit ChemPartner is building out its U.S. footprint in the heart of the bustling Boston biotech scene. The company’s new Boston Center of Excellence is…
The yearslong legal kerfuffle between IQVIA and Veeva Systems has come to a close, with the former adversaries setting aside their differences to launch a series of clinical and commercial…
More than two years after the FDA held a public workshop on measuring overall survival (OS) in clinical cancer trials, the agency has released a draft guidance on the topic,…